Compartir
Senescence, Senotherapeutics and Mitochondria (Volume 136) (Advances in Protein Chemistry and Structural Biology, Volume 136) (en Inglés)
Cakatay, Ufuk ; Can Atayik, Mehmet (Autor)
·
Academic Press
· Tapa Dura
Senescence, Senotherapeutics and Mitochondria (Volume 136) (Advances in Protein Chemistry and Structural Biology, Volume 136) (en Inglés) - Cakatay, Ufuk ; Can Atayik, Mehmet
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: España
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Lunes 24 de Junio y el
Jueves 04 de Julio.
Lo recibirás en cualquier lugar de Argentina entre 1 y 3 días hábiles luego del envío.
Reseña del libro "Senescence, Senotherapeutics and Mitochondria (Volume 136) (Advances in Protein Chemistry and Structural Biology, Volume 136) (en Inglés)"
Senescence, Senotherapeutics and Mitochondria, Volume 136 offers updates on this unique topics, with chapters covering Cellular Senescence in Aging: Molecular Basis, Implications and Therapeutic Interventions, Mitochondria-associated Cellular Senescence Mechanisms: Biochemical and Pharmacological Perspectives, Mitochondria in cell senescence: Friend or Foe?, The role of mitochondria and mitophagy in cell senescence, Small molecules targeting mitochondrial dysfunction for potential senotheraputics, Senolytic and senomorphic interventions to defy senescence-associated mitochondrial dysfunction, Mitochondrial targeting peptides and probes, Mitochondria-derived peptides in healthy ageing and therapy of age-related diseases, and much more. Other sections cover Targeting of mitostasis-proteostasis axis by antioxidant polysaccharides in neurodegeneration, Phytotherapeutic targeting of the mitochondria in neurodegenerative disorders, Melatonin as mitochondria-targeted drugs, Coenzyme Q-related compounds to maintain healthy mitochondria during aging, Changing ROS, NAD and AMP: a path to longevity via mitochondrial therapeutics, and more.
